What Medicare drug-cost changes are already confirmed for 2027?
Answered by 11 licensed agents
1. Maximum Part D deductible increases to $700
The maximum standard Part D deductible increases from $615 in 2026 to $700 in 2027. However, individual plans may offer lower deductibles or exempt certain medications from the deductible.
2. Annual prescription drug out-of-pocket cap increases to $2,400
The Part D annual out-of-pocket threshold increases from $2,100 in 2026 to $2,400 in 2027.
Once a beneficiary reaches this threshold through qualifying spending on covered Part D medications, they generally pay $0 for covered Part D drugs for the remainder of the calendar year.
3. Additional prescription drugs receive Medicare-negotiated prices
Beginning January 1, 2027, negotiated Medicare prices take effect for 15 additional high-cost Part D medications, bringing the total number of drugs with negotiated prices to 25.
These negotiated prices may help reduce costs, although individual savings depend on the drug, insurance plan, and benefit structure.
4. The Medicare Prescription Payment Plan continues
Beneficiaries can continue using this program to spread their out-of-pocket prescription drug expenses throughout the calendar year instead of paying large amounts at the pharmacy all at once.
This program does not reduce the total amount owed, but it can make expenses easier to manage.
5. Individual Part D plans may change significantly
Although CMS projects the national average standalone Part D premium will remain relatively stable in 2027, individual plans may have substantial changes in premiums, deductibles, formularies, pharmacy networks, and copayments.
My recommendation: Don't evaluate your 2027 prescription drug plan based on its monthly premium alone.
Answered by Michael McGarrigle on October 8, 2026
Broker Licensed in FL, AR, DE & 13 other states
- The maximum standard Part D deductible will increase from $615 to $700. Individual plans may charge a lower deductible or no deductible.
- The annual out-of-pocket limit for covered Part D medications will increase from $2,100 to $2,400. After reaching it, you pay $0 for covered Part D drugs for the rest of the year.
- Negotiated Medicare prices will begin for 15 additional medications, including Ozempic, Rybelsus, Wegovy, Trelegy Ellipta, Linzess and several cancer medications. Your personal savings will depend on your plan and how the drug is covered.
- The 2027 national base beneficiary premium will be $41.33, although this is not necessarily what an individual pays. Actual premiums vary by plan.
The insulin cost-sharing limit, $0 cost sharing for recommended Part D vaccines and the Medicare Prescription Payment Plan will continue.
Plan-specific premiums, formularies, pharmacy networks and copayments still need to be reviewed when 2027 plan information becomes available.
Answered by Lee Carroll on September 15, 2026
Agent Licensed in NC
CMS's April 2026 final rule permanently codifies the IRA's Part D redesign into law: no coverage gap, $0 cost-sharing after the annual cap. For 2027, the standard deductible rises to $700 (from $615) and the out-of-pocket cap rises to $2,400 (from $2,100). Two other 2027 changes matter for your wallet: the Part D Premium Stabilization Demonstration expires, so stand-alone plan premiums lose their federal cushion and may shift more by plan; and a second batch of 15 negotiated drugs gets maximum fair prices. A separate program covers GLP-1 drugs (Wegovy, Zepbound KwikPen, and Foundayo) for eligible beneficiaries July 2026-Dec 2027 at a flat $50 copay, which doesn't count toward the deductible or cap. Actual plan costs vary and appear in your ANOC letter by Sept 30, ahead of AEP (Oct 15-Dec 7). As always, review your current prescriptions with a licensed, local Medicare agent.
Answered by Marc Gilman on September 15, 2026
Agent Licensed in NH, FL, KS & 11 other states
Answered by Jeremy Harkins on September 14, 2026
Broker Licensed in TN, AR, CA & 5 other states
The Centers for Medicare & Medicaid Services (CMS) and federal rules have finalized several major cost parameters taking effect on January 1, 2027.
Answered by Christopher Horan on October 5, 2026
Agent Licensed in PA, DE, FL & NJ, NY, TX & VA
Annual out-of-pocket for the year will go from $2100 to $2400.
The fact that there is no more donut hole and your annual out-of-pocket costs are capped at $2400 for all covered drugs in your plan formulary is a great benefit. In addition, you can pay this monthly on a Medicare Prescription Plan at $200 a month.
Answered by Jeffrey Sodikoff on October 12, 2026
Agent Licensed in FL
Max out-of-pocket goes up to $2400 per year. Base Benefit premium is $41.33 nationally. That figure is what the Part D penalty is derived from.
The Temporary Stabilization subsidy was allowed to expire, which should additive to the premiums and/or copays for 2027.
The second set of 15 drugs was established where Medicare has negotiated the street price to a lower level.
Individual formularies are available through the respective insurance provider.
Answered by Ron Cronwell on October 14, 2026
Agent Licensed in TN
The important distinction for Medicare beneficiaries is between:
* Drug price reductions already in effect.
* Agreements with pharmaceutical companies that have been announced but may not yet be implemented.
* Proposed savings that still depend on government action or implementation.
Also, some Medicare drug-cost reductions began under the Biden administration, while Trump has announced additional initiatives.
What’s confirmed as of November 16, 2026?
Program Status
TrumpRx discounted drug purchasing Available since February 2026
Trump’s pharmaceutical company pricing agreements Agreements announced; some discounts available
Special $50 GLP-1 access for eligible seniors Administration reports program operating
Medicare’s first 10 negotiated drug prices In effect since January 2026
Medicare’s next 15 negotiated drug prices Confirmed for January 2027
The White House reported in August that it had reached pricing agreements with 26 pharmaceutical manufacturers. The White House +2
One important caution: TrumpRx discounts are not automatically applied to Medicare Part D copays. A lower advertised cash price does not necessarily mean a Medicare beneficiary will save money using it.
There is also a potential downside: the administration ended a temporary Part D premium subsidy program, which could increase some beneficiaries’ 2027 premiums.
My question for you
Are you referring to Trump’s announcement that Americans will pay the same lower drug prices as people in other countries?
If so, I can explain exactly what has been confirmed, what is already working, and whether your Medicare clients will actually see lower prescription costs in 2027.
Answered by Andre Hawkins on November 16, 2026
Broker Licensed in SC, AL, AZ & 14 other states
Answered by Mattie Macias on September 16, 2026
Agent Licensed in TN, MI, TX & VA
Answered by James Stang on October 26, 2026
Agent Licensed in OH, FL & KY
Answered by James Welch on October 10, 2026
Broker Licensed in MO
Tags: Advice for Seniors Coverage The Medicare System
Agents: Share Your Expertise
Have insights or experiences related to this topic? Help others by sharing your knowledge and answering this question.
Seniors: Ask a Question of Your Own
Questions are generally answered within 1 to 3 business days. Receive valuable perspectives from multiple licensed agents and brokers.
Ask a Question









